Informace o publikaci

Remote ischaemic preconditioning in coronary artery bypass surgery: a meta-analysis

Logo poskytovatele
Autoři

D ASCENZO Fabrizio CAVALLERO Erika MORETTI Claudio OMEDE Pierluigi SCIUTO Filippo RAHMAN Ishtiaq A. BONSER Robert S. YUNSEOK Jeon WAGNER Robert FREIBERGER Tomáš KUNST Gudrun MARBER Michael S. THIELMANN Matthias JI Bingyang AMR Yasser M. MODENA Maria Grazia ZOCCAI Giuseppe Biondi SHEIBAN Imad GAITA Fiorenzo

Rok publikování 2012
Druh Článek v odborném periodiku
Časopis / Zdroj Heart
Fakulta / Pracoviště MU

Středoevropský technologický institut

Citace
www http://heart.bmj.com/content/98/17/1267
Doi http://dx.doi.org/10.1136/heartjnl-2011-301551
Obor Kardiovaskulární nemoci včetně kardiochirurgie
Klíčová slova RANDOMIZED CONTROLLED-TRIAL; CARDIAC TROPONIN-I; GRAFT-SURGERY; REPERFUSION INJURY; MYOCARDIAL PROTECTION; CARDIOPROTECTION; ISOFLURANE; STRATEGIES; STATEMENT; HUMANS
Přiložené soubory
Popis Aim Randomised trials exploring remote ischaemic preconditioning (RIPC) in patients undergoing coronary artery bypass graft (CABG) surgery have yielded conflicting data regarding potential cardiovascular and renal protection, and are individually flawed by small sample size. Methods Three investigators independently searched the MEDLINE, EMBASE and Cochrane databases to identify randomised trials testing RIPC in patients undergoing CABG. Results Nine studies with 704 patients were included. Standardised mean difference of troponin I and T release showed a significant decrease (-0.36 (95% CI -0.62 to -0.09)). This difference held true after excluding the trials with cross-clamp fibrillation, the study with off-pump CABG and studies using a flurane as anaesthetic agent (-0.41 (95% CI -0.69 to -0.12), -0.38 (95% CI -0.70 to -0.07) and -0.37 (95% CI -0.63 to -0.12), respectively). A similar trend was also obtained for patients with multivessel disease (-0.41 (95% CI -0.73 to -0.08)). The trials evaluating postoperative creatinine reported a non-significant reduction (0.02 (95% CI -0.09 to 0.13)). Moreover, the length of in-hospital stay was not influenced by the kind of treatment (weighted mean difference 0.27 (95% CI -0.24 to 0.79)). Conclusion RIPC reduced the release of troponin in patients undergoing CABG. Larger randomised trials are needed to clarify the presence of a causal relationship between RIPC-induced troponin release and clinical adverse events.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info